Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

LEO Pharma - International Clinical Trial Manager

Diagnostics to deal with new diseases

Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...

Digitalisering och kliniska prövningar

Effektivare kliniska prövningar och ny teknologi för dokumentation av behandlingar - Digitaliseringen öppnar många möjligheter. Ola Björkman rapporterar från BIO i San Diego.

Hey Klementina Österberg ...

... CEO at GU Holding, which awards SEK 120, 000 to three female entrepreneurs.

Crafoord Prize to an American and two Japanese

Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Trio goes in for high tech medicines

The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.

New CEO to Swedish Tillotts Pharma

The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

New Nordic nutrition collaboration

Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.

Göteborgsfokuserad stiftelse får ny ordförande

Arne Lundbergs forskningsstiftelse får ny styrelseordförande då Björn Aschan lämnar efter tolv år på posten.

Hallå där Peter Zerhouni…

… som tillträdde som vd på biotechföretaget Index Pharmaceuticals tisdagen 1 april. Vad tar du med dig från din förra tjänst, som vd på vaccinbolaget Diamyd?

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...

International models among science parks

Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...

Biogaia's advance goes on

In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.

Ny design på klinstudie

I ett samarbete mellan FDA, NIH och läkemedelsindustrin utvärderas ett flertal behandlingar i samma studie.

Ny teknik kan upptäcka alzheimer tidigare

Detektion av specifika former av proteinet tau i blodprover kan ge tidigare diagnostik av personer med alzheimer, redan innan de första symptomen uppstår.

“Register och journalsystem borde vara samma sak”

Sverige ett framgångsrikt land inom medicinsk forskning, men hur ser det ut i dag och hur blir vi världsbäst?

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.